Giving birth following Vitro fertilization (IVF) increases the risk of developing gestational diabetes compared to conceiving naturally, according to Greek researchers. Women UN agencies offer birth when power-assisted generative technologies, like IVF, are at greater risk of developing the condition, according to a meta-analysis involving over two million pregnancies.
The analysis found a 53% increased risk of gestational diabetes in women who became pregnant via assisted reproduction techniques, compared with spontaneous conception. Estimates suggest that more than half a million babies are now born each year from techniques such as IVF and intracytoplasmic sperm injection (ICSI).
Pregnancies achieved by power-assisted replica square measure familiar to be related to additional medical specialty and perinatal complications, such as pre-eclampsia, placental anomalies, and low birth weight. However, whether assisted reproduction technologies are also linked with gestational diabetes was unclear, said the researchers, with previous studies, have yielded contradictory results.
Analysis of information from thirty-eight studies, involving nearly two million women and 163,302 cases of gestational diabetes, found that women who gave birth to singleton babies following assisted reproduction were 53% more likely to develop gestational diabetes. Specifically, 4,776 of out 63,760 women who became pregnant via assisted reproduction techniques developed gestational diabetes, compared with 158,526 out of 1,870,734 who had a spontaneous conception.
women who underwent assisted reproduction techniques were 42% more likely to develop physiological state polygenic disease compared with spontaneous conception. Dr. Panagiotis Anagnostis, from the Aristotle University of Thessaloniki, said: “This rigorous assessment of the best available evidence to date shows that singleton pregnancies achieved by IVF are linked with an increased risk of developing physiological state polygenic disease compared with pregnancies planned naturally.
The complications of the previous indicate that women at risk ought to be known and monitored, making certain they receive early detection and appropriate support and care.” The findings were presented at this year’s European Association for the Study of Diabetes (EASD) Annual Meeting in Barcelona, Spain.
